Avecho Biotechnology Ltd

AVE

Company Profile

  • Business description

    Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

  • Contact

    Unit A8, 2A Westall Road
    Clayton
    MelbourneVIC3168
    AUS

    T: +61 390025000

    https://www.avecho.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    34

Stocks News & Analysis

stocks

Strong results from cheap ASX share

The market responded favourably to results but shares still underpriced.
stocks

Anthropic’s Claude code security release is not bad news for cyber stocks

We believe cyber vendors will be able to adopt LLM’s for their benefit.
stocks

Earnings losers: TWE, GMG, SUN and more fall on weaker profits

Where companies fell short of market expectations in the third week of earnings.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,244.3016.50-0.18%
CAC 408,485.5511.62-0.14%
DAX 4024,914.5577.42-0.31%
Dow JONES (US)48,804.06821.91-1.66%
FTSE 10010,668.7116.03-0.15%
HKSE26,590.32491.59-1.82%
NASDAQ22,627.27258.79-1.13%
Nikkei 22557,321.09495.390.87%
NZX 50 Index13,532.31111.880.83%
S&P 5006,837.7571.76-1.04%
S&P/ASX 2009,022.3012.10-0.13%
SSE Composite Index4,117.4135.340.87%

Market Movers